Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Gives Aventis Early Access to High Throughput Platform

NEW YORK, March 3 (GenomeWeb News) - Affymetrix will give Aventis Pharmaceuticals early access to its high throughput microarray system, the company said today.

 

The new system, called GeneChip HTA, uses a standard 96-well plate footprint and can process 96 U133A human genome microarrays in parallel. It consists of an array plate, a scanner, tracking software, an assay protocol, and automation specifications.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.